Based on in vitro experiments demonstrating that TEPP-46 reduces osteoclast formation in an inflammatory environment by inhibiting PKM2 nuclear translocation, we further investigated the potential of TEPP-46 in treating periodontitis. Here, SPMIP8 is linked to periodontitis.